NO20055695L - Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer - Google Patents

Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer

Info

Publication number
NO20055695L
NO20055695L NO20055695A NO20055695A NO20055695L NO 20055695 L NO20055695 L NO 20055695L NO 20055695 A NO20055695 A NO 20055695A NO 20055695 A NO20055695 A NO 20055695A NO 20055695 L NO20055695 L NO 20055695L
Authority
NO
Norway
Prior art keywords
branched
linear
compounds
alkyl group
hydrogen atom
Prior art date
Application number
NO20055695A
Other languages
English (en)
Norwegian (no)
Inventor
Bernard Pirotte
Pascal De Tullio
Pierre Renard
Pierre Lestage
Daniel-Henri Caignard
Pierre Francotte
Laurence Danober
Emmanuel Graindorge
Stephane Boverie
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20055695L publication Critical patent/NO20055695L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20055695A 2003-05-05 2005-12-01 Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer NO20055695L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0305448A FR2854634B1 (fr) 2003-05-05 2003-05-05 Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2004/001070 WO2004099217A1 (fr) 2003-05-05 2004-05-04 Derives de thiadiazine et leur utilisation comme modulateurs positifs des recepteurs ampa

Publications (1)

Publication Number Publication Date
NO20055695L true NO20055695L (no) 2005-12-01

Family

ID=33306157

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055695A NO20055695L (no) 2003-05-05 2005-12-01 Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer

Country Status (21)

Country Link
US (1) US7476668B2 (pt)
EP (1) EP1620441A1 (pt)
JP (1) JP4461139B2 (pt)
KR (1) KR100741235B1 (pt)
CN (1) CN100363368C (pt)
AR (1) AR044245A1 (pt)
AU (1) AU2004236005B2 (pt)
BR (1) BRPI0410002A (pt)
CA (1) CA2524377C (pt)
EA (1) EA009240B1 (pt)
FR (1) FR2854634B1 (pt)
GE (1) GEP20084318B (pt)
HK (1) HK1088327A1 (pt)
MA (1) MA27732A1 (pt)
MX (1) MXPA05011823A (pt)
MY (1) MY136694A (pt)
NO (1) NO20055695L (pt)
NZ (1) NZ543214A (pt)
UA (1) UA80046C2 (pt)
WO (1) WO2004099217A1 (pt)
ZA (1) ZA200508660B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005020462D1 (de) 2004-08-25 2010-05-20 Essentialis Inc Pharmazeutische formulierungen von kalium-atp-kanalöffnern und deren verwendungen
EP3545958A1 (en) * 2006-01-05 2019-10-02 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
AR082618A1 (es) 2010-08-10 2012-12-19 Takeda Pharmaceutical Derivados de tiadiazina, composiciones farmaceuticas y usos
JP5901365B2 (ja) * 2012-03-12 2016-04-06 株式会社トクヤマ イミダート化合物の製造方法
CA2915405A1 (en) 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders
CN107922328B (zh) 2015-07-06 2020-05-19 公立大学法人横滨市立大学 和ampa受体特异性结合的新颖化合物
JP6241974B1 (ja) 2017-01-11 2017-12-06 公立大学法人横浜市立大学 霊長類生体の脳内ａｍｐａ受容体のイメージング方法、プログラム、及びスクリーニング方法
US10680583B1 (en) * 2019-02-26 2020-06-09 Xilinx, Inc. Control circuit for and method of controlling an operation of an integrated circuit device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733409A (en) * 1969-05-20 1973-05-15 Schering Corp Method of treating hypertension using thieno (1,2,4) thiadiazines
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
HUP0003999A3 (en) * 1997-07-16 2003-03-28 Novo Nordisk As Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them
RU2214405C2 (ru) * 1998-02-18 2003-10-20 НьюроСёрч А/С Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
BRPI0410002A (pt) 2006-04-25
CA2524377C (fr) 2010-08-24
MA27732A1 (fr) 2006-01-02
CN100363368C (zh) 2008-01-23
MY136694A (en) 2008-11-28
EP1620441A1 (fr) 2006-02-01
FR2854634A1 (fr) 2004-11-12
FR2854634B1 (fr) 2005-07-08
UA80046C2 (en) 2007-08-10
MXPA05011823A (es) 2006-05-25
GEP20084318B (en) 2008-03-10
HK1088327A1 (en) 2006-11-03
CA2524377A1 (fr) 2004-11-18
ZA200508660B (en) 2007-01-31
CN1798750A (zh) 2006-07-05
WO2004099217A1 (fr) 2004-11-18
AU2004236005B2 (en) 2010-01-21
KR20060006830A (ko) 2006-01-19
EA200501696A1 (ru) 2006-06-30
AU2004236005A1 (en) 2004-11-18
AR044245A1 (es) 2005-09-07
JP2006525292A (ja) 2006-11-09
US7476668B2 (en) 2009-01-13
US20070004709A1 (en) 2007-01-04
EA009240B1 (ru) 2007-12-28
JP4461139B2 (ja) 2010-05-12
KR100741235B1 (ko) 2007-07-19
NZ543214A (en) 2009-02-28

Similar Documents

Publication Publication Date Title
NO20055695L (no) Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer
IL164487A0 (en) 3-Heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
WO2005105732A8 (en) Substituted methyl aryl or heteroaryl amide compounds
MY142807A (en) Benzimidazole derivative and use thereof.
WO2008108386A1 (ja) 医薬組成物
CA2536870A1 (en) Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
EP1642880A4 (en) PROTEIN INHIBITOR OF THE HSP90 FAMILY
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
NO20071008L (no) Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
HUP0303801A2 (hu) Heterociklusos alkoxi-, alkil-tio- és alkil-amino-benzazol-származékok, mint 5-hidroxi-triptamin-6 ligandumok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE60223339D1 (de) Durch bicyclische aminogruppen substituierte verbindungen
MX2010010471A (es) Derivado de tetrahidroisoquinolina novedoso.
WO2009057733A1 (ja) 血管新生阻害活性を有する新規インドール誘導体
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
NO20053997L (no) Oligosaccharidderivat
NO20065323L (no) 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav
MY134226A (en) 1,2-dihydropyrazol-3-ones which control inflammatory cyctokines
MX2010008740A (es) Derivado de 3,8-diaminotetrahidroquinolina.
ES2195016T3 (es) Medicamento contra la trombocitopenia.
BRPI0516549A (pt) derivados de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)alquil ]fosfÈnico e métodos para sua fabricação
MY142362A (en) Pharmaceutical composition for promoting angiogenesis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application